tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Pantginis, 1188 are a BUY (97.62%), 28 are a HOLD (2.3%), 1 are a SELL (0.08%).
Analyst Joseph Pantginis, carries an average stock price target met ratio of 46.34% that have a potential upside of 53.96% achieved within 351 days. Previously, Joseph Pantginis worked at HC WAINWRIGHT.
Joseph Pantginis’s has documented 2,130 price targets and ratings displayed on 105 stocks. The coverage was on Healthcare, Industrials, Energy, Technology, Utilities sectors.
Most recent stock forecast was given on PHAR, Pharming Group NV.
Analyst best performing recommendations are on CDTX (CIDARA THERAPEUTICS).
The best stock recommendation documented was for CDTX (CIDARA THERAPEUTICS) at 6/18/2025. The price target of $41 was fulfilled within 5 days with a profit of $19.69 (92.4%) receiving and performance score of 184.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Jun-2020
$3.75
$-10.85 (-74.32%)
$68
6 years 3 months 13 days ago
(02-Jun-2020)
3/3 (100%)
$-9.1 (-70.82%)
144
Buy Since 15-Apr-2019
$35
$20.4 (139.73%)
$45
6 years 7 months 15 days ago
(31-Jan-2020)
0/2 (0%)
$26.6 (316.67%)
Hold Since 03-Jun-2019
7 years 3 months 12 days ago
(03-Jun-2019)
0/2 (0%)
$35.25 (88.68%)
Which stock is Joseph Pantginis most bullish on?
Which stock is Joseph Pantginis most reserved on?
